The purpose of this study is to evaluate safety, and tolerability of BMS-986036 and the effects the drug has on the body
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
63
Specified dose on specified days
Specified dose on specified days
WCCT Global
Cypress, California, United States
Incidence of adverse events (AEs)
Safety
Time frame: Up to 42 days
Incidence of serious adverse events (SAEs)
Safety
Time frame: Up to 42 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.